<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="702">
  <stage>Registered</stage>
  <submitdate>13/09/2005</submitdate>
  <approvaldate>30/09/2005</approvaldate>
  <actrnumber>ACTRN12605000562673</actrnumber>
  <trial_identification>
    <studytitle>Pilot study to examine the efficacy of terlipressin in the treatment of hepatorenal syndrome.</studytitle>
    <scientifictitle>A non-blinded randomised control study to examine the efficacy of terlipressin compared to standard care in improving renal function in patients with hepatorenal syndrome.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Hepatorenal syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Liver</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Standard care + terlipressin for hepatorenal syndrome
Duration of intervention is 5 days.</interventions>
    <comparator>Standard care (IV fluids +/- antibiotics if sepsis is suspected)</comparator>
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Primary end point is time from randomisation until serum creatinine has fallen to less than 0.15mmol/L</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Requirement for haemofiltration/dialysis</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Requirement for intensive care(ICU)</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Survival during inpatient stay</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Days in hospital</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Days in ICU</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Daily urine output</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in renal  and serumsodium concentration</outcome>
      <timepoint>From enrolment until day 5.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Cirrhotic patients admitted with hepatorenal syndrome (serum creatinine &gt;0.15 with urine sodium &lt;20 mmol).</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Use of other vasoactive drugs, pregnancy, age &lt;18 years, known severe coronary artery disease, AMI within previous 6 months, known intestinal iscchaemia, known severe cerebrovascular disease, CVA within previous 6 months and uncontrolled hypertension.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes</concealment>
    <sequence>Computer software performed by pharmacy department</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/02/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Austin Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Ferring Pharmaceuticals</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Paul Gow</name>
      <address>Department of Gastroenterology
Austin Health
Studley Rd
Heidelberg VIC 3084</address>
      <phone>+61 3 94965151</phone>
      <fax>+61 3 94963487</fax>
      <email>Paul.Gow@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Steve Lontos</name>
      <address>Department of Gastroenterology
Austin Health
Studley Rd
Heidelberg VIC 3084</address>
      <phone>+61 3 94965000</phone>
      <fax>+61 3 9496 3487</fax>
      <email>Steve.Lontos@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>